title: Aripiprazole and delirium.
abstract: BACKGROUND
  Delirium is a common condition frequently seen in consultation-liaison psychiatry. It is especially common among medically compromised patients and is an indicator of the severity of the medical illness. In addition, it is associated with a higher morbidity, mortality or longer hospitalization. Traditionally, haloperidol has been used to treat delirium-associated agitation. However, atypical antipsychotics are being increasingly used to treat delirium.
  
  
  METHODS
  Two case studies of delirium that were treated with 30 mg and 15 mg aripiprazole were described. The improvement of delirium was monitored using the Mini-Mental Status Exam (MMSE) and Delirium Rating Scale (DRS).
  
  
  RESULTS
  In both cases, the patients' confusion, disorientation, and agitation improved within 7 days of treatment. In the first case, the patient's MMSE score improved from 5 to 28, while his DRS score decreased from 28 to 6. In the second case, her MMSE score improved from 7 to 27, while her DRS score went down from 18 to 6.
  
  
  CONCLUSIONS
  To the best of our knowledge, this is the first report on the utilization of aripiprazole in the successful treatment of delirium. Although these cases showed positive results, future studies should be performed in order to further substantiate its use in delirium treatment.
authors.affiliation: SUNY Upstate Medical University, Syracuse, NY, USA. Alaoa@upstate.edu
authors.forename: Adekola O
authors.initials: AO
authors.lastname: Alao
authors.forename: Lindsay
authors.initials: L
authors.lastname: Moskowitz
mesh_terms: D000328:Adult; D000430:Alcohol Withdrawal Delirium / Q000175:diagnosis / Q000188:drug therapy; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D000068180:Aripiprazole; D003693:Delirium / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007362:Intensive Care Units; D008297:Male; D008609:Mental Status Schedule; D008875:Middle Aged; D010348:Patient Care Team; D010879:Piperazines / Q000008:administration & dosage*; D011569:Psychiatric Status Rating Scales; D011595:Psychomotor Agitation / Q000188:drug therapy; D015363:Quinolones / Q000008:administration & dosage*; D012017:Referral and Consultation; D006435:Renal Dialysis / Q000523:psychology
chemical_list: D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole